Buradasınız

Anasayfa » Content

Birinci basamakta hipertansiyona yaklaşım

Approach to hypertension in primary care

Journal Name:

  • Smyrna Tıp Dergisi

Publication Year:

  • 2012

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Hypertension is a common chronic disease in society. It is possible to reduce morbidity and mortality and avoid complications by effective preventive health practices. Risk factors of patients should be identified, early diagnosis and treatment should be provided, and if necessary, patients should be referred to seondary care in order to prevent complications. Education and lifestyle change should play an active role in the treatment of the patient.
Bookmark/Search this post with
Abstract (Original Language): 
Hipertansiyon toplumda sık görülen kronik bir hastalıktır. Etkin koruyucu hekimlik uygulamaları ile komplikasyonları önlemek, morbidite ve mortaliteyi azaltmak mümkündür. Hastaların risk faktörleri saptanmalı, erken tanı ve tedavisi sağlanmalı ve gerekirse komplikasyonların önlenmesi amacıyla üst basamağa sevki yapılmalıdır. Hasta tedavisinde eğitim ve yaşam biçimi değişikliği aktif rol oynamalıdır.
FULL TEXT (PDF): 
PDF icon arastirmax-birinci-basamakta-hipertansiyona-yaklasim.pdf
  • 1
62-67
  • Turkish

REFERENCES

References: 

1. Pickering G. Hypertension definitions, natural
histories and consequences. Am J Med 1972; 52:570-
583.
2. Heart Failure Society of America (HFSA) practice
guidelines. HFSA guidlines for management of
patients with heart failure caused by left ventricular
systolic dysfunction-pharmacological approaches. J
Card Fail 1999; 5:357-382.
3. Schocken DD, Benjamin EJ, Fonarow GC, Krumholz
HM, Levy D, Mensah GA, et al. Prevention of heart
failure: a scientific statement from the American
Heart Association Councils on Epidemiology and
Prevention, Clinical Cardiology, Cardiovascular
Nursing, and High Blood Pressure Research; Quality
of Care and Outcomes Research Interdisciplinary
Working Group; and Functional Genomics and
Translational Biology Interdisciplinary Working
Group. Circulation 2008; 117(19): 2544-2565.
4. McMinn TR Jr, Ross J Jr. Hereditary dilated
cardiomyopathy. Clin Cardiol 1995; 18(1):7-15.
5. Kırılmaz B, Tengiz İ. Aile Hekimliği Başucu Kitabı
2012; 598-631.
6. Kalan MK. Hipertansiyon Hastalarında
Anithipertansif İlaç Değişimleri, Bu değişimin Nedenleri
ve İlaç Değişimleri ile Hedef Tedavi Değerlerine
Ulaşma Oranlarının İncelenmesi. Uzmanlık tezi.
TCSB Şişli Etfal Eğitim ve Araştırma Hastanesi, Aile
Hekimliği Koordinatörlüğü, 2007.
7. Williams GH. Hypertensive vascular disease. In:
Harrison’s Principles of Internal Medicine
(Braunwald E, Fauci AS, Kasper DL, Hauser SL,
Longo DL, Jameson JL ed). 15th edition. McGraw
Hill. Vol 2, 2001; 1414-1430.
8. Massie BM, McPhee SJ. Systemic Hypertension. In:
Current Medica Diagnosis and Treatment (Tierney
LM, McPhee SJ, Papadakis MA ed). 44th edition.
McGraw Hill. 2005; 404-429.
9. Guidelines Subcommittee of the World Health
Organization: World Health Organization-
International Society of Hypertension Guidelines for
the Management of Hypertension. J Hypertens 1999;
17:151-183.
10. Arteriyel hipertansiyon tedavisi 2007 kılavuzu. Türk
Kardiyol Dern Arş 2007; 35(3):1-75.
11. Joint National Committee on Detection, Evaluation
and Treatment of High Blood Pressure. The Sixth
Report of the Joint National Committee on
Prevention, Detection and Treatment of High Blood
Pressure (JNC VI). Arch Intern Med 1997; 157:2413-
2446.
12. Guidelines Subcommittee of the World Health
Organization: World Health Organization-
International Society of Hypertension Guidelines for
the Management of Hypertension. J Hypertens 1999;
17:151-183.
13. Türk Kardiyoloji Derneği Ulusal Hipertansiyon Tedavi
ve Takip Kılavuzu 2000.
14. Abdelwahop W, Frishman W, Landau A.
Management of hypertensive urgencies and
emergencies. J Clin Pharmacol 1995; 35:747-762.
15. Kaplan NM. Management of hypertensive
emergencies. Lancet 1994; 344:1335-1338.
İletişim:
Uzm.Dr.Ziya Ömer
İzmir Üniversitesi Medicalpark Hastanesi
İç Hastalıkları Kliniği, İzmir, Türkiye
tel: +90.505.7981076
e-mail: ziyaomer@mynet.com

Thank you for copying data from http://www.arastirmax.com